Research Grant
[Cite as http://purl.org/au-research/grants/nhmrc/1117470]Researchers: Prof David Jans (Principal investigator) , Dr Kylie Wagstaff , Prof Christopher Porter , Prof Subhash Vasudevan , Prof Susan Charman
Brief description Dengue virus is the most important mosquito-borne viral disease, with 2/3 of the world's population at risk. There is currently no treatment available for dengue. Our proposal aims to progress a safe and effective new treatment (4-HPR) against Dengue towards the clinic, generating all the required pharmacokinetic and pre-clinical animal data necessary to progress to a future clinical trial in humans. We will also investigate the use of 4-HPR as a dengue preventative.
Funding Amount $AUD 877,454.12
Funding Scheme Development Grants
Notes Development Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1117470
- nhmrc : 1117470